Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07010614 · ClinicalTrials.gov registry record · NA
Brain Stimulation to the Hippocampus in Schizophrenia
A NA study of Mental Disorder and Schizophrenia Disorders, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07010614 is a NA study of Mental Disorder and Schizophrenia Disorders that is actively recruiting participants, run by Stanford University. The registered enrollment target is 60 participants, below the 322-participant average among 21 other Mental Disorder trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07010614, a NA study of Mental Disorder and Schizophrenia Disorders, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Schizophrenia - marked by delusions, hallucinations, and cognitive deficits - causes the most disability of any mental health condition, but existing treatments have significant side effect burden and are often ineffective. Disordered neural activity in the hippocampus likely contributes to schizophrenia symptoms, but to develop better therapies we need to understand whether hippocampal activity in schizophrenia can be systematically affected by non-invasive brain stimulation techniques like transcranial magnetic stimulation (TMS). This proposal will investigate the use of connectivity-guided theta burst brain stimulation to specifically target hippocampal function in schizophrenia, offering insights into fundamental hippocampal processes, schizophrenia pathophysiology, and potential avenues to use brain stimulation as a therapeutic tool in this devastating illness.
Conditions Studied
Interventions
- DEVICE TMS
- DEVICE Intracranial electrodes
- DEVICE TMS sham
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07010614
The ClinicalTrials.gov registry entry for NCT07010614 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 322-participant average among 21 other Mental Disorder trials with a reported enrollment target (81% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Mental Disorder appearing as the primary indexed condition, and to 3 interventions - of which TMS is the first listed.
NCT07010614 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07010614 about?
NCT07010614 is a clinical study titled "Brain Stimulation to the Hippocampus in Schizophrenia". Schizophrenia - marked by delusions, hallucinations, and cognitive deficits - causes the most disability of any mental health condition, but existing treatments have significant side effect burden and are often ineffective. Disordered neural activity in the hippocampus likely contributes to schizoph...
What is the current status of trial NCT07010614?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-10-01. Estimated completion is 2027-09-30.
What conditions does trial NCT07010614 study?
This clinical trial studies the following conditions: Mental Disorder, Schizophrenia Disorders, Psychotic Disorder.
What interventions are being tested in trial NCT07010614?
The interventions under investigation include: TMS (DEVICE), Intracranial electrodes (DEVICE), TMS sham (DEVICE).
Who is sponsoring clinical trial NCT07010614?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07010614 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mental Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ACT for HIV-Positive Men
RECRUITING · NA
-
Healthy ReStart Intervention to Improve Health and Functioning
RECRUITING · NA
-
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
RECRUITING · NA
-
Enhancing Immune Health Randomized Controlled Trial
RECRUITING · NA
-
Transdiagnostic Behavior Therapy Vs TAU for Adjustment Disorder Following Traumatic Event Exposure
RECRUITING · NA
-
FCT Study: Reducing the Need for Out-of-Home Placements
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.